- 1. ADR
- [Indicates that the observation is of an unexpected negative occurrence in the subject suspected to result from the subject's exposure to one or more agents. Observation values would be the symptom resulting from the reaction. ( HL7V3.0 )] (UMLS (NCI) C0559546) =Finding =ObservationType;
| - 51. adrenal ferredoxin
- [iron-sulfur protein which serves as an electron carrier in enzymatic steroid hydroxylation reactions in adrenal cortex mitochondria. ( CSP )] (UMLS (CSP) C0596044) =Organic Chemical ;
=ferredoxin;
|
- 2. ADR-529
- (UMLS (NCI) C0733405) =Organic Chemical; Pharmacologic Substance
| - 52. Adrenal Ganglioneuroblastoma
- [A ganglioneuroblastoma arising from the adrenal gland. ( NCI )] (UMLS (NCI) C1332176) Adrenal Gland Ganglioneuroblastoma;
=Neoplastic Process |
- 3. ADR-529/ASP/DOX/MP/MTX/PRED/VCR
- (UMLS (NCI) C0338303) =Therapeutic or Preventive Procedure
| - 53. Adrenal Gland Abscess
- (UMLS (NCI) C0919935) =Pathologic Function
|
- 4. ADR-529/ASP/DOX/MP/PRED/VCR
- (UMLS (NCI) C0338302) =Therapeutic or Preventive Procedure
| - 54. ADRENAL GLAND ANOMALY
- [ ] (UMLS (ICD9CM) C0158797) =Congenital Abnormality
|
- 5. ADR-529/BLEO/CTX/DOX/PRED/VCR/VP-16
- (UMLS (NCI) C0677847) =Therapeutic or Preventive Procedure ;
| - 55. Adrenal Gland Capsule
- (UMLS (NCI) C1181304) =Body Part, Organ, or Organ Component ;
|
- 6. ADR-529/BLEO/DOX/VCR/VP-16
- (UMLS (NCI) C0392942) =Therapeutic or Preventive Procedure ;
| - 56. Adrenal Gland Chromaffin Paraganglioma
- [usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the adrenal medulla or sympathetic paraganglia; the cardinal symptom, reflecting the increased secretion of epinephrine and norepinephrine, is hypertension, which may be persistent or intermittent. ( CSP )] (UMLS (NCI) C0031511) =Neoplastic Process ;
=Adrenal Gland Neoplasm;
Neoplasm of Paraganglion |
- 7. ADR-529/CTX/DOX/5-FU
- (UMLS (NCI) C0279446) =Therapeutic or Preventive Procedure
| - 57. Adrenal Gland Excision
- [excision of one (unilateral) or both (bilateral) of the adrenal glands; called also suprarenalectomy. ( CSP )] (UMLS (NCI) C0001632) =Therapeutic or Preventive Procedure ;
|
- 8. ADR-529/CTX/DOX/VCR
- (UMLS (NCI) C0279414) =Therapeutic or Preventive Procedure
| - 58. Adrenal Gland Injury
- (UMLS (NCI) C0347637) =Injury or Poisoning
|
- 9. ADR-529/DOX
- (UMLS (NCI) C0281254) =Therapeutic or Preventive Procedure ;
| - 59. ADRENAL GLAND INJURY-CL
- [ ] (UMLS (ICD9CM) C0160445) =Injury or Poisoning
|
- 10. ADR-529/DOX/G-CSF/TAX
- (UMLS (NCI) C0338281) =Therapeutic or Preventive Procedure ;
| - 60. ADRENAL GLAND INJURY-OPN
- [ ] (UMLS (ICD9CM) C0160452) =Injury or Poisoning
|
- 11. ADR-529/DOX/GM-CSF
- (UMLS (NCI) C0279104) =Therapeutic or Preventive Procedure
| - 61. Adrenal Gland Myelolipoma
- [A benign soft tissue lesion arising from the adrenal gland. It is composed of mature adipose and hematopoietic/lymphoid tissues. ( NCI )] (UMLS (NCI) C0206635) =Neoplastic Process =Adipose Tissue Neoplasm;
|
- 12. ADR-529/DOX/MP/MTX/PRED/VCR
- (UMLS (NCI) C0338305) =Therapeutic or Preventive Procedure
| - 62. Adrenal Gland Neoplasm
- [new abnormal adrenal gland tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (NCI) C0001624) =Neoplastic Process ;
|
- 13. ADR-529/DOX/TAX
- (UMLS (NCI) C0338280) =Therapeutic or Preventive Procedure ;
| - 63. Adrenal Gland Neuroblastoma
- [A neuroblastoma arising from the adrenal gland. ( NCI )] (UMLS (NCI) C0559460) =Neoplastic Process
|
- 14. ADRA1A
- [Alpha-1A-adrenergic receptor, encoded by the ADRA1A gene, regulates smooth muscle contraction, cellular growth and apoptosis. Alpha-1-adrenergic receptors (alpha-1-ARs) are members of the G protein-coupled receptor superfamily. There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation. This alpha-adrenergic receptor mediates its action by association with g proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(Q) and G(11) proteins. Alternative splicing of the ADRA1A gene generates 4 transcript variants, which encode 4 different isoforms with distinct C termini but having similar ligand binding properties. Its carboxyl-terminal SER or THR residues may be phosphorylated. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C0389726) =Amino Acid, Peptide, or Protein; Receptor
| - 64. Adrenal Gland Protein AD-004
- [Encoded by human TAF9 Gene (TAF2G Family), 264-aa 29-kDa nuclear TBP-Associated Factor 9 is a small TFIID subunit that binds to the basal transcription factor GTFIIB as well as transcriptional activators. A component of the PCAF complex and of the STAGA transcription coactivator-HAT complex, TAF9 is a p53 coactivator and interacts with viral transactivator VP16. TAF9 and TP53 bind via TP53 N-terminal amino acids that are essential for transcription. TFIID is composed of TBP and many evolutionarily conserved TAFs, which participate in basal transcription, serve as coactivators, and function in promoter recognition or modify general transcription factors to facilitate complex assembly and transcription initiation. Multimeric protein complex TFIID binds to the core promoter to position polymerase, serves as scaffold for assembly of the transcription complex, and acts as a channel for regulatory signals. (NCI) ( NCI )] (UMLS (NCI) C0540760) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 15. ADRA1A
- [This gene plays a regulatory role in the growth and proliferation of several cell types. ( NCI )] (UMLS (NCI) C1332026) ADRA1A Gene;
Adrenergic, Alpha-1A-, Receptor Gene;
=Gene or Genome ;
| - 65. Adrenal Gland Tuberculosis
- (UMLS (NCI) C0152889) =Disease or Syndrome
|
- 16. ADRA1B
- [Encoded by human protooncogene ADRA1B Gene (GPCR1 Family), 519-aa 56.8-kD Alpha-1B Adrenergic Receptor is a Gq/11-associated integral membrane protein that activates mitogenic PI-calcium second messenger responses and controls vascular tone and systolic blood pressure. ( NCI )] (UMLS (NCI) C0291339) =Amino Acid, Peptide, or Protein; Receptor
| - 66. Adrenal hemorrhage of fetus or newborn
- [ ] (UMLS (ICD9CM) C0158957) =Disease or Syndrome ;
|
- 17. ADRA1B
- [This gene is involved in the induction of neoplastic transformation and receptor signaling. ( NCI )] (UMLS (NCI) C1332027) ADRA1B Gene;
Adrenergic, Alpha-1B-, Receptor Gene;
=Gene or Genome ;
| - 67. Adrenal Hormone
- [Hormones made from cholesterol and protein produced by the adrenal glands and regulate electrolyte balance, blood pressure, inflammation, blood sugar balance, and immune system control. ( NCI )] (UMLS (NCI) C1445654) =Organic Chemical; Pharmacologic Substance; Hormone
|
- 18. ADRA2A
- [Alpha-2-adrenergic receptors are members of the G protein-coupled receptor superfamily. These receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. They include 3 highly homologous subtypes: alpha2A, alpha2B, and alpha2C. Alpha-2A-adrenergic receptor is encoded by the ADRA2A gene. Both the alpha2A and alpha2C subtypes are required for normal presynaptic control of transmitter release from sympathetic nerves in the heart and from central noradrenergic neurons. The alpha2A subtype inhibits transmitter release at high stimulation frequencies, whereas the alpha2C subtype modulates neurotransmission at lower levels of nerve activity. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C0391398) =Amino Acid, Peptide, or Protein; Receptor ;
| - 68. adrenal hypertension
- [hypertension caused by excessive production of mineralocorticoids. ( CSP )] (UMLS (CSP) C0264641) =Disease or Syndrome =adrenal disorder;
Blood Pressure, High |
- 19. ADRA2A
- [This gene plays a role in the regulation of neurotransmitter release from nerves and neurons in the central nervous system. ( NCI )] (UMLS (NCI) C1332028) ADRA2A Gene;
Adrenergic, Alpha-2A-, Receptor Gene;
=Gene or Genome ;
| - 69. ADRENAL HYPOFUNCTION NEC
- [ ] (UMLS (ICD9CM) C0154205) =Disease or Syndrome
|
- 20. ADRA2B
- [Alpha-2-adrenergic receptors are members of the G protein-coupled receptor superfamily. They include 3 highly homologous subtypes: alpha2A, alpha2B, and alpha2C. These receptors have a critical role in regulating neurotransmitter release from sympathetic nerves and from adrenergic neurons in the central nervous system. The alpha2B subtype, encoded by the ADRA2B gene is associated with eIF-2B, a guanine nucleotide exchange protein that functions in regulation of translation. A polymorphic variant of the alpha2B subtype, which lacks 3 glutamic acids from a glutamic acid repeat element, decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. This polymorphic form is also associated with reduced basal metabolic rate in obese subjects and may therefore contribute to the pathogenesis of obesity. This gene contains no introns in either its coding or untranslated sequences. (From LocusLink) ( NCI )] (UMLS (NCI) C0540641) =Amino Acid, Peptide, or Protein; Receptor ;
| - 70. ADRENAL INCISION
- (UMLS (ICD9CM) C0193676) =Therapeutic or Preventive Procedure
|
- 21. ADRA2B
- [This gene is involved in transcriptional regulation and G protein-coupled receptor signal transduction. ( NCI )] (UMLS (NCI) C1332029) ADRA2B Gene;
Adrenergic, Alpha-2B-, Receptor Gene;
=Gene or Genome ;
| - 71. ADRENAL LESION EXCISION
- (UMLS (ICD9CM) C0193702) =Therapeutic or Preventive Procedure
|
- 22. ADRB1
- [Encoded by human ADRB1 Gene (GPCR1 Family), 477-aa 51-kDa conserved Beta-1-Adrenergic Receptor is an integral membrane protein receptor for catecholamine epinephrine and norepinephrine neurotransmitters that activates adenylate cyclase through G protein action. ADRB1 phosphorylation by beta-adrenergic receptor kinase mediates receptor desensitization. Agonist and antagonist drugs selective for beta-1 receptors have important applications in clinical medicine. (NCI) ( NCI )] (UMLS (NCI) C0001642) =Amino Acid, Peptide, or Protein; Receptor
| - 72. Adrenal Mass
- (UMLS (NCI) C0342500) =Disease or Syndrome ;
|
- 23. ADRB2
- [Encoded by human ADRB2 Gene (GPCR Family), Beta-2 Adrenergic Receptor directly associates with one of its effectors, class C L-type calcium channel Ca(V)1.2. This receptor-channel complex also contains a G protein, an adenylyl cyclase, cAMP-dependent kinase, and the counterbalancing phosphatase, PP2A. This signaling complex assembly ensures specific and rapid signaling by this G protein-coupled receptor that stimulates adenylyl cyclase activity. Polymorphisms, point mutations, and/or downregulation of ADRB2 are associated with nocturnal asthma, obesity, and type 2 diabetes. (From LocusLink) ( NCI )] (UMLS (NCI) C0001643) =Amino Acid, Peptide, or Protein; Receptor
| - 73. adrenal medulla
- [inner part of the adrenal gland; it synthesizes, stores and releases catecholamines. ( CSP )] (UMLS (CSP) C0001629) =Body Part, Organ, or Organ Component ;
|
- 24. ADRB2
- [This gene is involved in maintaining the integrity and rate of G protein-coupled receptor signal transduction. ( NCI )] (UMLS (NCI) C1367657) ADRB2 Gene;
Adrenergic, Beta-2-, Receptor, Surface Gene =Gene or Genome ;
| - 74. adrenal medulla cancer
- [any new and abnormal growth of the inner part of the adrenal gland; specifically a new growth of tissue of the inner part of the adrenal gland in which the growth is uncontrolled and progressive. ( CSP )] (UMLS (CSP) C0596046) =Neoplastic Process ;
=Adrenal Gland Neoplasm;
|
- 25. ADRBK1
- [Beta-adrenergic receptor kinase 1 (ADRBK1), encoded by the ADRBK1 gene, phosphorylates the beta-2-adrenergic receptor and mediates agonist-specific desensitization observed at high agonist concentrations. ADRBK1, an ubiquitous cytosolic enzyme, translocates from the cytosol to the plasma membrane upon agonist stimulation and specifically phosphorylates the activated form of the beta-adrenergic and related G-protein-coupled receptors. Heart failure is accompanied by severely impaired beta-adrenergic receptor (beta-AR) function. An important mechanism for the rapid desensitization of beta-AR function is agonist-stimulated receptor phosphorylation by ADRBK1, an enzyme known to be elevated in failing human heart tissue. Abnormal coupling of beta-adrenergic receptor to G protein is involved in the pathogenesis of the failing heart. Inhibition of ADRBK1 is a novel mode of therapy. (From LocusLink) ( NCI )] (UMLS (NCI) C0753114) BARK1;
Beta-Adrenergic Receptor Kinase 1;
BETA-ARK1;
Beta-ARK-1;
EC 2.7.1.126;
G-Protein Coupled Receptor Kinase 2;
GRK2;
=Amino Acid, Peptide, or Protein; Enzyme; Receptor | - 75. Adrenal Medulla Carcinoma
- [A carcinoma that has spread to the adrenal medulla from an adjacent or distant anatomic site. (NCI05) ( NCI )] (UMLS (NCI) C1334717) Metastatic Carcinoma to Adrenal Medulla;
Metastatic Carcinoma to the Adrenal Medulla =Neoplastic Process |
- 26. ADRBK1
- [This gene is involved in signal transduction. ( NCI )] (UMLS (NCI) C1366490) ADRBK1 Gene;
Adrenergic, Beta, Receptor Kinase 1 Gene =Gene or Genome | - 76. adrenal medulla hormone
- [chemical substances having a specific regulatory effect on the activity of a certain organ or organs; secreted by the inner part of the adrenal gland. ( CSP )] (UMLS (CSP) C0301822) =Neuroreactive Substance or Biogenic Amine; Hormone =neurohormone;
=Adrenal;
(.+-.)-Noradrenaline |
- 27. ADRBK2
- [Adrenergic, Beta, Receptor Kinase 2 (ADRBK2), encoded by the ADRBK2 gene, specifically phosphorylates the agonist-occupied and -activated form of the beta-adrenergic and related G protein-coupled receptors. ADRBK2 regulates desensitization of G protein-coupled receptors. Overall, the ADRBK2 enzyme has 85% amino acid similarity with ADRBK1, with the protein kinase Catalytic Domain Having 95% Similarity. (From Locuslink) ( NCI )] (UMLS (NCI) C0285499) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 77. Adrenal Medullary Hyperplasia
- (UMLS (NCI) C1332177) =Pathologic Function
|
- 28. ADRBK2
- [This gene plays a role in signal transduction. ( NCI )] (UMLS (NCI) C1332030) ADRBK2 Gene;
Adrenergic, Beta, Receptor Kinase 2 Gene;
=Gene or Genome ;
| - 78. ADRENAL NERVE DIVISION
- [ ] (UMLS (ICD9CM) C0196617) =Therapeutic or Preventive Procedure
|
- 29. Adrenal
- [paired glands situated in the retroperitoneal tissues at the superior pole of each kidney. ( CSP )] (UMLS (HL7) C0001625) =Body Part, Organ, or Organ Component ;
| - 79. ADRENAL OPERATION NEC
- [ ] (UMLS (ICD9CM) C0176123) =Therapeutic or Preventive Procedure
|
- 30. Adrenal
- [active sympathomimetic hormone from the adrenal medulla in most species; it stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels; used in treatment of asthma and cardiac failure and to delay absorption of local anesthetics. ( CSP )] (UMLS (NCI) C0014563) =Organic Chemical; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine; Hormone =adrenergic agent;
catecholamine;
Ethanolamines;
vasoconstrictor;
adrenal medulla hormone;
[AU100] SYMPATHOMIMETICS (ADRENERGICS);
[RE102] BRONCHODILATORS, SYMPATHOMIMETIC,INHALATION;
=Adrenaline Hydrochloride;
(.+-.)-Noradrenaline;
DIPIVEFRIN;
epinephryl borate;
EPINEPHRINE,RACEMIC;
Adrenaline Bitartrate;
Adrenaline Hydrochloride;
EPINEPHRINE,RACEMIC;
Adrenaline Bitartrate;
EPINEPHRINE 0.1 MG/ML;
EPINEPHRINE 5 MG/ML;
EPINEPHRINE 0.2 MG/ACTUAT;
EPINEPHRINE 0.15 MG/0.3ML;
EPINEPHRINE 0.3 MG/0.3ML;
EPINEPHRINE 8 %;
EPINEPHRINE 1:200000;
EPINEPHRINE 1:100000;
EPINEPHRINE 1:50000;
| - 80. ADRENAL REIMPLANTATION
- [ ] (UMLS (ICD9CM) C0176125) =Therapeutic or Preventive Procedure
|
- 31. Adrenal Agent
- [Pharmacological agents which affect the function of the adrenal glands. ( NCI )] (UMLS (NCI) C0280077) =Pharmacologic Substance
| - 81. ADRENAL REPAIR
- (UMLS (ICD9CM) C0193745) =Therapeutic or Preventive Procedure
|
- 32. Adrenal Artery
- (UMLS (NCI) C0226407) =Body Part, Organ, or Organ Component
| - 82. Adrenal Rest Neoplasm
- [A benign, testicular or ovarian tumor, derived from adrenal embryonic rest cells. It is composed of hyperplastic adrenal cortical tissue, and it is associated with congenital adrenal hyperplasia. ( NCI )] (UMLS (NCI) C0001630) =Neoplastic Process ;
|
- 33. Adrenal Blockade
- [Treatment to block production of adrenal hormones. ( NCI )] (UMLS (NCI) C0279034) =Therapeutic or Preventive Procedure
| - 83. Adrenal Scintigraphy
- (UMLS (NCI) C0860838) =Diagnostic Procedure
|
- 34. adrenal cancer
- [A primary or metastatic malignant neoplasm affecting the adrenal gland. (NCI05) ( NCI )] (UMLS (CSP) C0750887) MALIGN NEOPL ADRENAL;
Malignant Adrenal Gland Neoplasm;
Malignant Adrenal Gland Tumor;
Malignant Adrenal Neoplasm;
Malignant Adrenal Tumor;
Malignant Neoplasm of Adrenal Gland;
Malignant Neoplasm of the Adrenal Gland;
Malignant Tumor of Adrenal Gland;
Malignant Tumor of the Adrenal Gland =Neoplastic Process ;
| - 84. adrenal transplantation
- [transferring adrenal cells, tissues or whole glands within an individual, between individuals of the same species, or between individuals of different species. ( CSP )] (UMLS (CSP) C0596047) =Therapeutic or Preventive Procedure ;
=endocrine transplantation;
|
- 35. adrenal circulation
- [ ] (UMLS (CSP) C0597768) =Organ or Tissue Function ;
| - 85. ADRENAL VESSEL LIGATION
- [ ] (UMLS (ICD9CM) C0176124) =Therapeutic or Preventive Procedure
|
- 36. Adrenal Cortex
- [The outer layer of the adrenal gland. It secretes mineralocorticoids, androgens, and glucocorticoids. (MeSH) ( NCI )] (UMLS (NCI) C0001613) =Body Part, Organ, or Organ Component ;
| - 86. adrenalin oxidase
- [An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. ( MSH )] (UMLS (CSP) C0026454) =Amino Acid, Peptide, or Protein; Enzyme =amine oxidoreductase;
Enzymatic Pathway of Metabolism |
- 37. Adrenal Cortex Adenocarcinoma
- [A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells. Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women. Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes. Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival. ( NCI )] (UMLS (NCI) C0206686) =Neoplastic Process ;
=adenocarcinoma;
Adrenal Cortex Tumor | - 87. adrenergic
- [ ] (UMLS (CSP) C0599756) =Functional Concept ;
|
- 38. Adrenal Cortex Clear Cell Adenoma
- [An adenoma of the adrenal cortex composed of neoplastic clear cells containing intracytoplasmic lipid droplets. ( NCI )] (UMLS (NCI) C0334334) =Neoplastic Process
| - 88. adrenergic agent
- [drugs that selectively bind to and activate adrenergic receptors or mimic the actions of adrenergic transmitters; for adrenergic antagonists, see ANTIADRENERGIC AGENT. ( CSP )] (UMLS (CSP) C0001637) =Pharmacologic Substance ;
|
- 39. Adrenal Cortex Compact Cell Adenoma
- [An adenoma of the adrenal cortex composed of neoplastic compact cells with eosinophilic cytoplasm. ( NCI )] (UMLS (NCI) C0334332) =Neoplastic Process
| - 89. adrenergic agonist
- [Drugs that bind to and activate adrenergic receptors. ( MSH )] (UMLS (CSP) C0001648) =Pharmacologic Substance ;
|
- 40. Adrenal Cortex Glomerulosa Cell Adenoma
- [An adenoma of the adrenal cortex composed of neoplastic cells with cytologic features of glomerulosa cells. ( NCI )] (UMLS (NCI) C0334335) =Neoplastic Process
| - 90. adrenergic antagonist
- [group of drugs that bind to but do not activate adrenergic receptors; they block the actions of the endogenous adrenergic transmitters epinepherine and norepinepherine. ( CSP )] (UMLS (CSP) C0242889) =Pharmacologic Substance ;
=neuropharmacologic agent;
neurotransmitter antagonist;
Adrenergic Receptor Interactions;
=Adrenergic alpha-Antagonists;
2-[N-p'-Tolyl-N-(m'-hydroxyphenyl)aminomethyl]imidazoline;
rauwolfia alkaloid;
2,4,5-Trihydroxyphenethylamine;
beta antiadrenergic agent;
Adrenergic alpha-Antagonists;
Adrenergic beta-Antagonists |
- 41. adrenal cortex hormone
- [any of the 21-carbon steroids elaborated by the adrenal cortex (excluding the sex hormones of adrenal origin) in response to adrenocorticotropic hormone (ACTH) released by the pituitary gland or to angiotensin II; called also adrenocorticoid, corticoid, adrenal cortical or adrenocortical steroid, and adrenocortical or cortical hormone. ( CSP )] (UMLS (CSP) C0001617) =Steroid; Pharmacologic Substance; Hormone ;
| - 91. adrenergic block
- [ ] (UMLS (CSP) C0599515) =Therapeutic or Preventive Procedure ;
|
- 42. Adrenal Cortex Hyperplasia
- (UMLS (NCI) C0342494) =Disease or Syndrome ;
| - 92. adrenergic receptor
- [family of G protein coupled receptors sensitive to epinephrine, norepinephrine, and their analogs, found in smooth and cardiac muscle, autonomic ganglia, brain, and elsewhere. ( CSP )] (UMLS (CSP) C0034783) =Amino Acid, Peptide, or Protein; Receptor ;
=neurotransmitter receptor;
=alpha adrenergic receptor;
beta adrenergic receptor;
|
- 43. Adrenal Cortex Mixed Cell Adenoma
- [An adenoma of the adrenal cortex composed of a mixed neoplastic cellular population, including varying numbers of neoplastic clear and compact cells. ( NCI )] (UMLS (NCI) C0334336) =Neoplastic Process
| - 93. Adrenocortical Suppressant
- (UMLS (NCI) C0280044) =Pharmacologic Substance
|
- 44. Adrenal Cortex Neoplasm
- [A benign or malignant (primary or metastatic) neoplasm affecting the adrenal cortex. (NCI05) ( NCI )] (UMLS (NCI) C0001618) =Neoplastic Process ;
| - 94. adrenodoxin
- [An iron-sulfur protein which serves as an electron carrier in enzymatic steroid hydroxylation reactions in adrenal cortex mitochondria. The electron transport system which catalyzes this reaction consists of adrenodoxin reductase, NADP, adrenodoxin, and cytochrome P-450. ( MSH )] (UMLS (CSP) C0001657) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 45. Adrenal Cortical Insufficiency
- [The inability of the adrenal gland to produce adequate amounts of cortisol. ( NCI )] (UMLS (NCI) C0405580) =Disease or Syndrome
| - 95. ADRENOGENITAL DISORDERS
- (UMLS (ICD9CM) C0701163) =Disease or Syndrome
|
- 46. Adrenal cortical steroids causing adverse effects in therapeutic use
- [ ] (UMLS (ICD9CM) C0261784) =Injury or Poisoning
| - 96. adrenogenital syndrome
- [Abnormal SEX DIFFERENTIATION caused by disorders of the GONADS or the ADRENAL GLANDS, such as CONGENITAL ADRENAL HYPERPLASIA and ADRENAL CORTEX NEOPLASMS. Due to abnormal steroid biosynthesis, clinical features include VIRILISM in females; FEMINIZATION in males; or precocious sexual development in children. ( MSH )] (UMLS (CSP) C0302280) =Congenital Abnormality
|
- 47. Adrenal Cyst
- (UMLS (NCI) C0342501) =Finding
| - 97. adrenoleukodystrophy
- [childhood genetic disease, transmitted as an X-linked recessive trait, characterized by diffuse abnormality of cerebral white matter and adrenal atrophy; mental deterioration progresses to dementia, aphasia, apraxia, dysarthria, and loss of vision. ( CSP )] (UMLS (CSP) C0162309) =Disease or Syndrome =adrenal disorder;
Adrenal Gland Hypofunction;
Genetic Condition;
LEUKODYSTROPHY;
Sphingolipidoses;
PEROXISOMAL DISORDERS;
Hereditary Central Nervous System Demyelinating Diseases;
|
- 48. adrenal disorder
- [pathologic condition or abnormal functioning of either or both of the paired glands situated in the retroperitoneal tissues at the superior pole of the kidneys or adrenal glands. ( CSP )] (UMLS (CSP) C0001621) =Disease or Syndrome ;
| - 98. adrenomedullin
- [A 52-amino acid peptide with multi-functions. It was originally isolated from PHEOCHROMOCYTOMA and ADRENAL MEDULLA but is widely distributed throughout the body including lung and kidney tissues. Besides controlling fluid-electrolyte homeostasis, adrenomedullin is a potent vasodilator and can inhibit pituitary ACTH secretion. ( MSH )] (UMLS (CSP) C0215825) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 49. ADRENAL DISORDER NEC
- [ ] (UMLS (ICD9CM) C0154207) =Disease or Syndrome
| - 99. adriamycin
- [ ] (UMLS (CSP) C0085752) =Organic Chemical; Pharmacologic Substance
|
- 50. ADRENAL EXPLORATION NOS
- [ ] (UMLS (ICD9CM) C0405570) =Diagnostic Procedure
| - 100. Adriamycin-DNA Complex
- [A complex comprised of Doxorubicin linked to DNA to enhance the topoisomerase II-mediated interaction with the DNA base pairs and reduce cardiotoxicity associated with anthracyclines. (NCI) ( NCI )] (UMLS (NCI) C0058725) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
|
home
